📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity. (2024)

First Author: McGlone ER

Attributed to: RAMP2 and the glucagon receptor: important in the pathogenesis of non-alcoholic fatty liver disease? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.biopha.2024.116888

PubMed Identifier: 38861859

Publication URI: http://europepmc.org/abstract/MED/38861859

Type: Journal Article/Review

Volume: 176

Parent Publication: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

ISSN: 0753-3322